Puma Biotechnology Inc — movimiento de fondos (NASDAQ:PBYI) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 773 K20.65 M-15.83 M27.01 M38.92 M41.8 M 41.8 M Flujo de caja de las actividades de inversión 23.4 M-10.88 M7.1 M-19.13 M-20.44 M-36.19 M -36.19 M Flujo de caja de las actividades financieras 68 K-31.93 M12.22 M0-33.85 M-45.2 M -45.2 M Flujo de caja libre -19.23 M20.65 M-15.83 M14.37 M38.86 M41.73 M 41.73 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Noticias

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Puma Biotechnology 4T 2025: ingresos de NERLYNX suben 15%

Puma Biotechnology reporta sólidos resultados del cuarto trimestre de 2025

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

Puma Biotech en Conferencia TD Cowen: Crecimiento y Disciplina Financiera

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates